825 related articles for article (PubMed ID: 30500983)
1. miR-146b overexpression ameliorates lipopolysaccharide-induced acute lung injury in vivo and in vitro.
He R; Li Y; Zhou L; Su X; Li Y; Pan P; Hu C
J Cell Biochem; 2019 Mar; 120(3):2929-2939. PubMed ID: 30500983
[TBL] [Abstract][Full Text] [Related]
2. Enforced expression of miR-125b attenuates LPS-induced acute lung injury.
Guo Z; Gu Y; Wang C; Zhang J; Shan S; Gu X; Wang K; Han Y; Ren T
Immunol Lett; 2014 Nov; 162(1 Pt A):18-26. PubMed ID: 25004393
[TBL] [Abstract][Full Text] [Related]
3. Depression of lncRNA MINCR antagonizes LPS-evoked acute injury and inflammatory response via miR-146b-5p and the TRAF6-NFkB signaling.
Gao W; Zhang Y
Mol Med; 2021 Oct; 27(1):124. PubMed ID: 34602057
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of miR-146a contributes to the suppression of inflammatory responses in LPS-induced acute lung injury.
Zeng Z; Gong H; Li Y; Jie K; Ding C; Shao Q; Liu F; Zhan Y; Nie C; Zhu W; Qian K
Exp Lung Res; 2013 Sep; 39(7):275-82. PubMed ID: 23848342
[TBL] [Abstract][Full Text] [Related]
5. MiR-150 attenuates LPS-induced acute lung injury via targeting AKT3.
Li P; Yao Y; Ma Y; Chen Y
Int Immunopharmacol; 2019 Oct; 75():105794. PubMed ID: 31398659
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of LncRNA MALAT1 contributes to the suppression of inflammatory responses by up-regulating miR-146a in LPS-induced acute lung injury.
Dai L; Zhang G; Cheng Z; Wang X; Jia L; Jing X; Wang H; Zhang R; Liu M; Jiang T; Yang Y; Yang M
Connect Tissue Res; 2018 Nov; 59(6):581-592. PubMed ID: 29649906
[TBL] [Abstract][Full Text] [Related]
7. MiR-490 alleviates sepsis-induced acute lung injury by targeting MRP4 in new-born mice.
Lin J; Lin Z; Lin L
Acta Biochim Pol; 2021 Mar; 68(2):151-158. PubMed ID: 33751878
[TBL] [Abstract][Full Text] [Related]
8. Rhesus θ-Defensin-1 Attenuates Endotoxin-induced Acute Lung Injury by Inhibiting Proinflammatory Cytokines and Neutrophil Recruitment.
Jayne JG; Bensman TJ; Schaal JB; Park AYJ; Kimura E; Tran D; Selsted ME; Beringer PM
Am J Respir Cell Mol Biol; 2018 Mar; 58(3):310-319. PubMed ID: 28954201
[TBL] [Abstract][Full Text] [Related]
9. Silencing of long non-coding RNA MEG3 alleviates lipopolysaccharide-induced acute lung injury by acting as a molecular sponge of microRNA-7b to modulate NLRP3.
Liao H; Zhang S; Qiao J
Aging (Albany NY); 2020 Aug; 12(20):20198-20211. PubMed ID: 32852284
[TBL] [Abstract][Full Text] [Related]
10. Vasoactive intestinal peptide overexpression mediated by lentivirus attenuates lipopolysaccharide-induced acute lung injury in mice by inhibiting inflammation.
Sun GY; Yang HH; Guan XX; Zhong WJ; Liu YP; Du MY; Luo XQ; Zhou Y; Guan CX
Mol Immunol; 2018 May; 97():8-15. PubMed ID: 29544087
[TBL] [Abstract][Full Text] [Related]
11. Protective effects of intratracheally administered quercetin on lipopolysaccharide-induced acute lung injury.
Takashima K; Matsushima M; Hashimoto K; Nose H; Sato M; Hashimoto N; Hasegawa Y; Kawabe T
Respir Res; 2014 Nov; 15(1):150. PubMed ID: 25413579
[TBL] [Abstract][Full Text] [Related]
12. MiR-24 inhibits inflammatory responses in LPS-induced acute lung injury of neonatal rats through targeting NLRP3.
Lin Y; Yang Y
Pathol Res Pract; 2019 Apr; 215(4):683-688. PubMed ID: 30600184
[TBL] [Abstract][Full Text] [Related]
13. Functional roles of CD26/DPP4 in lipopolysaccharide-induced lung injury.
Sato S; Kawasaki T; Hatano R; Koyanagi Y; Takahashi Y; Ohnuma K; Morimoto C; Dudek SM; Tatsumi K; Suzuki T
Am J Physiol Lung Cell Mol Physiol; 2024 May; 326(5):L562-L573. PubMed ID: 38469626
[TBL] [Abstract][Full Text] [Related]
14. Human mesenchymal stem cells overexpressing the IL-33 antagonist soluble IL-1 receptor-like-1 attenuate endotoxin-induced acute lung injury.
Martínez-González I; Roca O; Masclans JR; Moreno R; Salcedo MT; Baekelandt V; Cruz MJ; Rello J; Aran JM
Am J Respir Cell Mol Biol; 2013 Oct; 49(4):552-62. PubMed ID: 23656573
[TBL] [Abstract][Full Text] [Related]
15. miR-23b Attenuates LPS-Induced Inflammatory Responses in Acute Lung Injury via Inhibition of HDAC2.
Luo ZF; Jiang XH; Liu H; He LY; Luo X; Chen FC; Tan YL
Biochem Genet; 2021 Apr; 59(2):604-616. PubMed ID: 33415668
[TBL] [Abstract][Full Text] [Related]
16. Pirfenidone ameliorates lipopolysaccharide-induced pulmonary inflammation and fibrosis by blocking NLRP3 inflammasome activation.
Li Y; Li H; Liu S; Pan P; Su X; Tan H; Wu D; Zhang L; Song C; Dai M; Li Q; Mao Z; Long Y; Hu Y; Hu C
Mol Immunol; 2018 Jul; 99():134-144. PubMed ID: 29783158
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of miR-221 alleviates LPS-induced acute lung injury via inactivation of SOCS1/NF-κB signaling pathway.
Wang T; Jiang L; Wei X; Dong Z; Liu B; Zhao J; Wang L; Xie P; Wang Y; Zhou S
Cell Cycle; 2019 Aug; 18(16):1893-1907. PubMed ID: 31208297
[TBL] [Abstract][Full Text] [Related]
18. MiR-21-5p modulates LPS-induced acute injury in alveolar epithelial cells by targeting SLC16A10.
Zeng H; Zhou Y; Liu Z; Liu W
Sci Rep; 2024 May; 14(1):11160. PubMed ID: 38750066
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-92a antagonism attenuates lipopolysaccharide (LPS)-induced pulmonary inflammation and injury in mice through suppressing the PTEN/AKT/NF-κB signaling pathway.
Fu L; Zhu P; Qi S; Li C; Zhao K
Biomed Pharmacother; 2018 Nov; 107():703-711. PubMed ID: 30138892
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of miR-145-5p alleviated LPS-induced acute lung injury.
Yu YL; Yu G; Ding ZY; Li SJ; Fang QZ
J Biol Regul Homeost Agents; 2019; 33(4):1063-1072. PubMed ID: 31353880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
